 Gregory Way
Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 9 | 2025 | 644 | 2.820 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2025 | 752 | 1.800 |
Why?
| | Machine Learning | 8 | 2025 | 493 | 1.710 |
Why?
| | Software | 5 | 2025 | 665 | 1.460 |
Why?
| | Microscopy | 5 | 2025 | 152 | 1.460 |
Why?
| | Single-Cell Analysis | 2 | 2025 | 313 | 1.230 |
Why?
| | Gene Expression Profiling | 9 | 2025 | 1774 | 0.980 |
Why?
| | Transcriptome | 4 | 2025 | 971 | 0.950 |
Why?
| | Pyroptosis | 1 | 2025 | 3 | 0.950 |
Why?
| | Molecular Imaging | 1 | 2023 | 56 | 0.820 |
Why?
| | Aggression | 3 | 2015 | 202 | 0.820 |
Why?
| | Polypharmacology | 1 | 2022 | 2 | 0.760 |
Why?
| | Cystadenocarcinoma, Serous | 2 | 2024 | 77 | 0.700 |
Why?
| | Cells | 1 | 2021 | 25 | 0.700 |
Why?
| | Neurofibromin 1 | 2 | 2019 | 26 | 0.690 |
Why?
| | Data Compression | 1 | 2020 | 5 | 0.670 |
Why?
| | Forecasting | 1 | 2021 | 389 | 0.610 |
Why?
| | Ovarian Neoplasms | 4 | 2024 | 565 | 0.600 |
Why?
| | Zebrafish | 3 | 2025 | 499 | 0.590 |
Why?
| | ras Proteins | 2 | 2019 | 153 | 0.570 |
Why?
| | Neoplasms | 5 | 2020 | 2671 | 0.550 |
Why?
| | Glioblastoma | 2 | 2019 | 345 | 0.530 |
Why?
| | Algorithms | 7 | 2025 | 1704 | 0.530 |
Why?
| | Gene Silencing | 2 | 2018 | 195 | 0.530 |
Why?
| | Gene Expression | 2 | 2021 | 1502 | 0.490 |
Why?
| | Genome-Wide Association Study | 3 | 2025 | 1431 | 0.480 |
Why?
| | Behavior, Animal | 3 | 2015 | 501 | 0.470 |
Why?
| | Genetic Association Studies | 1 | 2016 | 377 | 0.450 |
Why?
| | Phenotype | 7 | 2025 | 3196 | 0.450 |
Why?
| | Genome, Human | 3 | 2025 | 425 | 0.430 |
Why?
| | Personality | 1 | 2015 | 132 | 0.410 |
Why?
| | Models, Biological | 1 | 2020 | 1783 | 0.390 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2129 | 0.380 |
Why?
| | Cell Line, Tumor | 6 | 2023 | 3412 | 0.350 |
Why?
| | Humans | 29 | 2025 | 137585 | 0.300 |
Why?
| | Reproducibility of Results | 4 | 2025 | 3284 | 0.290 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1396 | 0.270 |
Why?
| | Databases, Genetic | 2 | 2018 | 237 | 0.250 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 2025 | 45 | 0.240 |
Why?
| | Phosphate-Binding Proteins | 1 | 2025 | 6 | 0.240 |
Why?
| | DiGeorge Syndrome | 1 | 2025 | 32 | 0.240 |
Why?
| | Apoptosis | 2 | 2025 | 2553 | 0.230 |
Why?
| | Chromosome Deletion | 1 | 2025 | 115 | 0.230 |
Why?
| | Craniofacial Abnormalities | 1 | 2025 | 72 | 0.230 |
Why?
| | Caspase 1 | 1 | 2025 | 144 | 0.220 |
Why?
| | Information Storage and Retrieval | 1 | 2025 | 118 | 0.220 |
Why?
| | Quantitative Trait Loci | 2 | 2024 | 380 | 0.220 |
Why?
| | Genomics | 3 | 2025 | 795 | 0.210 |
Why?
| | Bortezomib | 1 | 2023 | 54 | 0.210 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 46 | 0.210 |
Why?
| | Boronic Acids | 1 | 2023 | 37 | 0.210 |
Why?
| | Cell Line | 2 | 2021 | 2847 | 0.210 |
Why?
| | Interleukin-1beta | 1 | 2025 | 372 | 0.200 |
Why?
| | Pyrazines | 1 | 2023 | 90 | 0.200 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 156 | 0.200 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 558 | 0.190 |
Why?
| | Signal Transduction | 4 | 2019 | 5079 | 0.190 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2025 | 455 | 0.190 |
Why?
| | Neuroblastoma | 2 | 2020 | 160 | 0.190 |
Why?
| | Budgets | 1 | 2021 | 13 | 0.190 |
Why?
| | High-Throughput Screening Assays | 1 | 2023 | 158 | 0.190 |
Why?
| | Interdisciplinary Research | 1 | 2021 | 27 | 0.180 |
Why?
| | Publications | 1 | 2021 | 47 | 0.180 |
Why?
| | Schizophrenia | 1 | 2025 | 439 | 0.170 |
Why?
| | Cell Culture Techniques | 1 | 2023 | 363 | 0.170 |
Why?
| | Neoplasm Grading | 2 | 2024 | 307 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 248 | 0.170 |
Why?
| | Bone Development | 1 | 2021 | 54 | 0.170 |
Why?
| | N-Myc Proto-Oncogene Protein | 1 | 2020 | 9 | 0.170 |
Why?
| | Biological Assay | 1 | 2021 | 124 | 0.170 |
Why?
| | Supervised Machine Learning | 1 | 2020 | 17 | 0.170 |
Why?
| | Bone Diseases | 1 | 2021 | 62 | 0.170 |
Why?
| | Epigenomics | 1 | 2020 | 115 | 0.160 |
Why?
| | Reward | 1 | 2021 | 244 | 0.150 |
Why?
| | Information Dissemination | 1 | 2021 | 218 | 0.150 |
Why?
| | Mentoring | 1 | 2021 | 149 | 0.150 |
Why?
| | Cooperative Behavior | 1 | 2021 | 451 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2019 | 528 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 801 | 0.150 |
Why?
| | Atlases as Topic | 1 | 2018 | 10 | 0.140 |
Why?
| | Recombinational DNA Repair | 1 | 2018 | 16 | 0.140 |
Why?
| | Bone and Bones | 1 | 2021 | 317 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2019 | 268 | 0.140 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 22 | 0.140 |
Why?
| | Acid Phosphatase | 1 | 2017 | 20 | 0.140 |
Why?
| | Biomedical Technology | 1 | 2018 | 43 | 0.140 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 156 | 0.140 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2017 | 71 | 0.140 |
Why?
| | Bone Density | 2 | 2021 | 489 | 0.140 |
Why?
| | Phosphoproteins | 1 | 2019 | 338 | 0.130 |
Why?
| | Nonlinear Dynamics | 1 | 2018 | 88 | 0.130 |
Why?
| | Systems Biology | 1 | 2018 | 67 | 0.130 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2017 | 91 | 0.130 |
Why?
| | GTPase-Activating Proteins | 1 | 2017 | 83 | 0.130 |
Why?
| | Bayes Theorem | 1 | 2018 | 405 | 0.130 |
Why?
| | Motivation | 1 | 2021 | 570 | 0.130 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 872 | 0.130 |
Why?
| | Multiple Myeloma | 1 | 2019 | 252 | 0.130 |
Why?
| | Proteomics | 2 | 2021 | 1111 | 0.130 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 289 | 0.130 |
Why?
| | Cichlids | 1 | 2015 | 4 | 0.120 |
Why?
| | Genetic Loci | 1 | 2017 | 288 | 0.120 |
Why?
| | Animals | 6 | 2025 | 36940 | 0.120 |
Why?
| | Tumor Microenvironment | 1 | 2019 | 674 | 0.120 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 305 | 0.120 |
Why?
| | Cluster Analysis | 1 | 2016 | 499 | 0.120 |
Why?
| | Models, Genetic | 1 | 2018 | 600 | 0.110 |
Why?
| | Video Recording | 1 | 2015 | 180 | 0.110 |
Why?
| | DNA Methylation | 1 | 2017 | 643 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2426 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 692 | 0.090 |
Why?
| | Chromosome Mapping | 2 | 2024 | 523 | 0.090 |
Why?
| | Female | 8 | 2024 | 73304 | 0.090 |
Why?
| | Brain Neoplasms | 1 | 2019 | 1238 | 0.080 |
Why?
| | Mutation | 4 | 2025 | 3958 | 0.080 |
Why?
| | Sex Characteristics | 1 | 2015 | 762 | 0.080 |
Why?
| | Molecular Sequence Annotation | 2 | 2019 | 99 | 0.070 |
Why?
| | Chromatin | 2 | 2021 | 519 | 0.060 |
Why?
| | Child | 3 | 2021 | 21935 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2017 | 2253 | 0.060 |
Why?
| | Male | 5 | 2021 | 67762 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2021 | 1250 | 0.060 |
Why?
| | Cell Shape | 1 | 2024 | 57 | 0.050 |
Why?
| | Cell Adhesion | 1 | 2025 | 466 | 0.050 |
Why?
| | Mutant Proteins | 1 | 2024 | 103 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 125 | 0.050 |
Why?
| | Neural Stem Cells | 1 | 2025 | 156 | 0.050 |
Why?
| | Astrocytes | 1 | 2025 | 210 | 0.050 |
Why?
| | Zebrafish Proteins | 1 | 2025 | 288 | 0.050 |
Why?
| | Alleles | 1 | 2025 | 891 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2024 | 620 | 0.040 |
Why?
| | Osteoblasts | 1 | 2021 | 126 | 0.040 |
Why?
| | Antigens, CD20 | 1 | 2019 | 29 | 0.040 |
Why?
| | Gene Editing | 1 | 2021 | 80 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2020 | 138 | 0.040 |
Why?
| | Osteogenesis | 1 | 2021 | 188 | 0.040 |
Why?
| | Osteosarcoma | 1 | 2019 | 74 | 0.040 |
Why?
| | Rhabdomyosarcoma | 1 | 2019 | 72 | 0.040 |
Why?
| | Mitochondria | 1 | 2025 | 948 | 0.040 |
Why?
| | Wilms Tumor | 1 | 2019 | 86 | 0.040 |
Why?
| | Genes, Neoplasm | 1 | 2018 | 22 | 0.040 |
Why?
| | Sarcoma, Ewing | 1 | 2019 | 97 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2025 | 1164 | 0.040 |
Why?
| | Loss of Heterozygosity | 1 | 2018 | 51 | 0.040 |
Why?
| | Gene Ontology | 1 | 2018 | 53 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2018 | 115 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 320 | 0.030 |
Why?
| | Disease | 1 | 2018 | 98 | 0.030 |
Why?
| | Wnt Proteins | 1 | 2018 | 133 | 0.030 |
Why?
| | CpG Islands | 1 | 2017 | 157 | 0.030 |
Why?
| | Adult | 1 | 2020 | 37929 | 0.030 |
Why?
| | Drug Design | 1 | 2018 | 167 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 422 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2017 | 182 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2018 | 216 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 1060 | 0.030 |
Why?
| | Neurons | 1 | 2025 | 1590 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 366 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2021 | 712 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2018 | 327 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2018 | 767 | 0.030 |
Why?
| | Precision Medicine | 1 | 2019 | 429 | 0.030 |
Why?
| | DNA Damage | 1 | 2018 | 420 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2018 | 480 | 0.030 |
Why?
| | Sexual Behavior, Animal | 1 | 2015 | 57 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 1050 | 0.030 |
Why?
| | Histones | 1 | 2020 | 636 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 916 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1389 | 0.030 |
Why?
| | Brain | 1 | 2025 | 2668 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 978 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2189 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 660 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 900 | 0.020 |
Why?
| | Delivery of Health Care | 1 | 2018 | 951 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2018 | 1069 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5472 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4295 | 0.020 |
Why?
| | Child, Preschool | 1 | 2021 | 11074 | 0.020 |
Why?
| | Aged | 1 | 2024 | 23961 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 13209 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 33479 | 0.010 |
Why?
| | Mice | 1 | 2019 | 17787 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 21513 | 0.010 |
Why?
|
|
Way's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|